The Harry Potter movies are adored for good reason, but they could have done a better job when it came to portraying a few ...

Many Black inventors struggled through hardship, poverty, and, in some circumstances, slavery. Still, they prevailed and proved their genius to the world. The following are but a few of the many ...

n 2025, after carding a flawless 8-under 64 in the final round at Black Desert Resort, it was ultimately Haeran Ryu who collected her third career LPGA Tour victory at the inaugural Black Desert ...

Regulus Therapeutics Inc. (NASDAQ:RGLS) announced some great news today, which is that it would be acquired by Novartis AG (NVS) for $7 per share in cash. However, there is room for additional ...

Novartis (NYSE:NVS) has agreed to acquire biopharmaceutical firm Regulus Therapeutics (NASDAQ:RGLS) for an initial payment of $7.00 a share in cash at closing, or $0.8B. The upfront cash portion ...

Novartis NOVN0.71%increase; green up pointing triangle has agreed to acquire Regulus Therapeutics RGLS-0.38%decrease; red down pointing triangle for a total equity value of up to roughly $1.7 billion.

Novartis AG agreed to buy US biotech Regulus Therapeutics Inc. in a deal that could be valued at up to $1.7 billion. The Swiss company will pay $7 a share in cash upfront through a subsidiary ...

Novartis will pay $800 million upfront to acquire Regulus Therapeutics, a San Diego biotechnology company that launched nearly two decades ago with plans to make drugs capable of targeting small ...

Call of Duty: Black Ops 6 players have branded one fan-favorite killstreak as ‘useless’ as it is now the “worst version” of itself. Over the last few years, Call of Duty has tried to ...

Novartis' established global development and commercial capabilities will enable this important new medicine to reach patients if approved," said Jay Hagan, CEO of Regulus Therapeutics.

Novartis will pay $800 million upfront to acquire Regulus Therapeutics, a San Diego biotechnology company that launched nearly two decades ago with plans to make drugs capable of targeting small ...